Testing Glial Pathways to HAAF in Human Subjects Using Carbon 13 Magnetic Resonance Spectroscopy (GLIMpSE)
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Contacts and Locations
Study Locations
-
-
Louisiana
-
Baton Rouge, Louisiana, United States, 70808-4124
- Pennington Biomedical Research Center
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Male
- BMI 20.0-24.9 kg/m2
- 18-40 years old
- Willing to reside at Pennington Biomedical for 4 days
Exclusion Criteria:
- Type 1 diabetes mellitus
- Type 2 diabetes mellitus
- Fasting glucose ≥ 110 mg/dL (determined at screening visit)
- Hyperketonuria >15 mg/dL, (determined at screening visit)
- Contraindication to MRI
- History of or current eating disorder
- History of obsessive compulsive disorder
- Current use of any medication (excluding over-the-counter pain medication)
- Contraindication to prolonged fasting
- Consume >10 alcoholic drinks/week
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Healthy Men
|
72 hour fasting
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Percent Enrichment of Bicarbonate as Measured by Magnetic Resonance Spectroscopy (MRS)
Time Frame: 80 hours
|
80 hours
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Cerebral Metabolic Rate of Acetate Ascertained Through Mathematical Modeling of MRS Data
Time Frame: 80 hours
|
80 hours
|
|
Astroglial TCA Cycle Rate Ascertained Through Mathematical Modeling of MRS Data
Time Frame: 80 hours
|
80 hours
|
|
Glucose Level
Time Frame: 72 hours
|
72 hours
|
|
Change in Leptin Levels
Time Frame: 72 hours
|
72 hours
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: David McDougal, PhD, Pennington Biomedical Rsrch Ct
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- PBRC 2015-019
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.